Minerva Biotechnologies Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Minerva Biotechnologies Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10792
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Minerva Biotechnologies Corp (Minerva) is a cancer therapy and regenerative medicine company that develops immunotherapies and cancer drugs. The company offers antibody for T-cell immunotherapy, which is used in advanced breast and ovarian cancers; and humanized antibodies used for prostate and breast cancer. It offers anti-metastasis antibody that block the metastatic growth factor and transition from a regular cancer cell to a metastatic cancer cell. Minerva’s stem cell technology is utilized to generate human naive state induced pluripotent stem cells using a single, naturally occurring human stem cell growth factor for the treatment of cancer. The company’s technology is also used to facilitate regenerative therapies targeting diseases of the heart, central nervous system, liver, diabetes, and macular degeneration. Minerva is headquartered in Waltham, Massachusetts, the US.

Minerva Biotechnologies Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Minerva Biotech Raises USD2 Million in Venture Financing 10
Licensing Agreements 11
Minerva Biotech Enters into Licensing Agreement with ID Pharma 11
Minerva Biotech Enters into Licensing Agreement with iPS Academia 12
Minerva Biotechnologies Corp – Key Competitors 13
Minerva Biotechnologies Corp – Key Employees 14
Minerva Biotechnologies Corp – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
04/03/2018: Minerva Biotechnologies Presenting at the American Association for Cancer Research (AACR) Conference 16
Feb 14, 2017: Minerva Biotechnologies Launches AlphaSTEM, A Naive Stem Cell Culture System 17
Other Significant Developments 18
Feb 26, 2018: Minerva Biotechnologies Announces CellSystems as European Distributor of AlphaSTEM, Naïve Stem Cell Culture System 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Key Facts 2
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Minerva Biotechnologies Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Minerva Biotech Raises USD2 Million in Venture Financing 10
Minerva Biotech Enters into Licensing Agreement with ID Pharma 11
Minerva Biotech Enters into Licensing Agreement with iPS Academia 12
Minerva Biotechnologies Corp, Key Competitors 13
Minerva Biotechnologies Corp, Key Employees 14

List of Figures
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Minerva Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Minerva Biotechnologies Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Boston Scientific Corporation:企業のM&A・提携・投資分析
    Boston Scientific Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Boston Scientific Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • MannKind Corp (MNKD):企業のM&A・提携動向(医療機器分野)
    Summary MannKind Corp (MannKind) is a bio-pharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products to treat diseases such as diabetes and cancer. The company’s product portfolio comprises one marketed product Afrezza, a rapid-acting inhaled insul …
  • Gakken Holdings Co. Ltd. (9470):企業財務及び戦略的SWOT分析
    Summary Gakken Holdings Co. Ltd. (Gakken), formerly Gakken Co., Ltd is a books and magazines publication company that develops, manufactures and markets books, magazines and other stationery items. The company’s products portfolio includes illustrated and pictorial books, play books, science kits, b …
  • Suzuken Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Suzuken Co., Ltd. Mergers and A …
  • First Takaful Insurance Company KSCC:企業の戦略・SWOT・財務分析
    SummaryFirst Takaful Insurance Company KSCC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • HomeWorks Tri-County Electric Cooperative Inc:企業の戦略的SWOT分析
    HomeWorks Tri-County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Rural Areas Electricity Company SAO.C.:企業の戦略的SWOT分析
    Rural Areas Electricity Company SAO.C. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Multi-Color Corporation (LABL):企業の財務及び戦略的SWOT分析
    Summary Multi-Color Corporation (Multi-Color) is a global label manufacturer that produces packaging labels. The company's products include cut and stack labels, heat transfer labels, in-mold label, pressure sensitive labels, shrink sleeve labels, and others. Its printing technologies include rotogr …
  • 3M Company (MMM):企業のM&A・提携動向(発電分野)
    Summary 3M Company (3M) is a diversified technology company that specializes in the development, manufacture and marketing of a wide range of innovative products. 3M develops technology platforms, including adhesives, abrasives, light management, microreplication, nonwoven materials, nanotechnology, …
  • Rusforest, Ltd. (formerly Vostok Caspian Oil, Ltd.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Rusforest, Ltd. (formerly Vosto …
  • Western Digital Corporation:企業のM&A・提携・投資分析
    Western Digital Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Western Digital Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • freenet AG (FNTN):企業概要、財務及び戦略的SWOT分析
    Summary freenet AG (freenet) is a telecommunication service provider. The company provides network-independent telecommunication services. It concentrates on the field of mobile voice and data services. freenet sells mobile communications devices and accessories. freenet offers its service to the mo …
  • Amita Technologies Inc. (5233):企業財務及び戦略的SWOT分析
    Summary Amita Technologies Inc. (Amita Tech) is a battery manufacturer that designs and manufactures Lithium-Ion Polymer battery packs and related products. The company develops process and methods for cell design, pack design, the manufacturing process, and automation equipment. Its products includ …
  • Tennessee Valley Authority(エネルギー分野):企業M&A動向
    Summary Tennessee Valley Authority (TVA) is a corporate agency providing electricity for business customers and local power companies serving nine million people in parts of seven southeastern states. The agency generates power utilizing diverse sources of energy such as hydro, nuclear, fossil fuel …
  • Technip SA (TEC):企業のM&A・提携動向(石油・ガス分野)
    Summary Technip SA (Technip) is a provider of project management, engineering and construction services to energy sector. It offers a comprehensive portfolio of technologies and services for the subsea oil and gas developments to the largest and most complex offshore and onshore infrastructures. The …
  • First Horizon National Corporation – Land:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' First Horizon National Corporat …
  • Sinochem Group:企業の戦略・SWOT・財務分析
    SummarySinochem Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • reMYND(製薬・医療分野):企業M&A動向
    Summary reMYND is a contract1 research organization (CRO). The company develops disease-modifying treatments for Alzheimer’s, Parkinson’s, diabetes, and other protein misfolding disorders. It operates through two business segments such as Contract research and Drug discovery. reMYND’s Contract resea …
  • EndoStim Inc:医療機器:M&Aディール及び事業提携情報
    Summary EndoStim Inc (EndoStim) is a medical device company that provides therapeutic solutions. The company develops and commercializes a neurostimulation system for the treatment of severe gastroesophageal reflux disease. It concentrates on the treatment of gastroesophageal reflux disease through …
  • C-Rad AB (CRAD B):企業のM&A・提携動向(医療機器分野)
    Summary C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets medical equipment for use in advanced radiation therapy. The company offers products which include Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating application …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆